CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pacific Shuanglin Bio-pharmacy Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pacific Shuanglin Bio-pharmacy Co Ltd
No.1 Xinfeng East Road
Dongjiang Town, Mazhang District
Phone: +86 7592931218p:+86 7592931218 ZHANJIANG, GNG  201100  China Ticker: 000403000403
Business Summary
Pacific Shuanglin Bio-pharmacy Co Ltd, formerly Southern Shuanglin Bio-pharmacy Co Ltd, formerly Zhenxing Biopharmaceutical & Chemical Co., Ltd., is a China-based company mainly engaged in the research, development, production and sales of blood products. The Company's main products are human albumin, intravenous immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin. The Company mainly operates its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board HaoLi 51 10/25/2023 10/25/2023
Co-Chairman of the Board ShaolanFu 81 12/11/2023
Chief Financial Officer YehongWang 32 3/26/2021 3/26/2021
12 additional Officers and Directors records available in full report.

Business Names
Business Name
000403
Sanjiu Yigong Biopharmaceutical & Chem

General Information
Number of Employees: 2,426 (As of 12/31/2023)
Outstanding Shares: 731,074,913 (As of 11/13/2024)
Shareholders: 17,901
Stock Exchange: SHE
Fax Number: +86 7592931213


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024